Published in J Neurochem on December 01, 2002
Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med (2005) 3.42
CNS immune privilege: hiding in plain sight. Immunol Rev (2006) 3.13
TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med (2007) 2.62
A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. J Neurochem (2009) 2.37
TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell (2015) 2.15
Toll-like receptors in central nervous system glial inflammation and homeostasis. J Neurosci Res (2006) 1.91
Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease. ASN Neuro (2010) 1.58
microRNA-34a-Mediated Down-Regulation of the Microglial-Enriched Triggering Receptor and Phagocytosis-Sensor TREM2 in Age-Related Macular Degeneration. PLoS One (2016) 1.46
Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation. Brain (2008) 1.38
Coding variants in TREM2 increase risk for Alzheimer's disease. Hum Mol Genet (2014) 1.36
Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2. Mol Neurodegener (2014) 1.36
Differential gene expression in LPS/IFNgamma activated microglia and macrophages: in vitro versus in vivo. J Neurochem (2009) 1.34
Microglia during development and aging. Pharmacol Ther (2013) 1.30
Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke. J Neurosci (2015) 1.28
Microglia and the control of autoreactive T cell responses. Neurochem Int (2006) 1.28
Developmental regulation of TREM2 and DAP12 expression in the murine CNS: implications for Nasu-Hakola disease. Neurochem Res (2008) 1.27
The cellular response in neuroinflammation: The role of leukocytes, microglia and astrocytes in neuronal death and survival. Clin Neurosci Res (2006) 1.24
A rose by any other name? The potential consequences of microglial heterogeneity during CNS health and disease. Neurotherapeutics (2007) 1.22
Functional diversity of microglia - how heterogeneous are they to begin with? Front Cell Neurosci (2013) 1.14
Regulation of TREM2 expression by an NF-кB-sensitive miRNA-34a. Neuroreport (2013) 1.13
TREM2 sustains microglial expansion during aging and response to demyelination. J Clin Invest (2015) 1.12
Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages. Am J Pathol (2005) 1.11
Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment. Expert Opin Drug Metab Toxicol (2008) 1.11
P2X4 receptors in activated C8-B4 cells of cerebellar microglial origin. J Gen Physiol (2010) 1.07
Regulation of TREM expression in hepatic macrophages and endothelial cells during acute endotoxemia. Exp Mol Pathol (2007) 1.06
Role of microglia in neuronal degeneration and regeneration. Semin Immunopathol (2009) 1.06
TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy. Neuron (2016) 1.01
Animal Models of MS Reveal Multiple Roles of Microglia in Disease Pathogenesis. Neurol Res Int (2011) 1.00
TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post-Mortem Temporal Cortices. Brain Pathol (2014) 0.98
Microglial immunoreceptor tyrosine-based activation and inhibition motif signaling in neuroinflammation. Int J Alzheimers Dis (2010) 0.98
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers. EMBO Mol Med (2016) 0.97
TREM2 variants: new keys to decipher Alzheimer disease pathogenesis. Nat Rev Neurosci (2016) 0.97
DAP12 Stabilizes the C-terminal Fragment of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) and Protects against LPS-induced Pro-inflammatory Response. J Biol Chem (2015) 0.95
Neurobiology of microglial action in CNS injuries: receptor-mediated signaling mechanisms and functional roles. Prog Neurobiol (2014) 0.94
Tumor necrosis factor-alpha (TNF-alpha) regulates Toll-like receptor 2 (TLR2) expression in microglia. J Neurochem (2007) 0.92
Signal regulatory protein-beta1: a microglial modulator of phagocytosis in Alzheimer's disease. Am J Pathol (2009) 0.92
Regulating amyloidogenesis through the natural triggering receptor expressed in myeloid/microglial cells 2 (TREM2). Front Cell Neurosci (2014) 0.92
Amniotic fluid sTREM-1 in normal pregnancy, spontaneous parturition at term and preterm, and intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med (2010) 0.91
Expression of the phagocytosis-essential protein TREM2 is down-regulated by an aluminum-induced miRNA-34a in a murine microglial cell line. J Inorg Biochem (2013) 0.91
Selective reduction in microglia density and function in the white matter of colony-stimulating factor-1-deficient mice. J Neurosci Res (2009) 0.89
Upregulation of the stress-associated gene p8 in mouse models of demyelination and in multiple sclerosis tissues. Glia (2006) 0.86
More evidence for association of a rare TREM2 mutation (R47H) with Alzheimer's disease risk. Neurobiol Aging (2015) 0.85
Prioritization of candidate disease genes by topological similarity between disease and protein diffusion profiles. BMC Bioinformatics (2013) 0.85
Induction of Golli-MBP expression in CNS macrophages during acute LPS-induced CNS inflammation and experimental autoimmune encephalomyelitis (EAE). ScientificWorldJournal (2007) 0.85
Neuroinflammation in advanced canine glaucoma. Mol Vis (2010) 0.84
DAP12 signaling: from immune cells to bone modeling and brain myelination. J Clin Invest (2003) 0.84
Triggering receptor expressed on myeloid cells-1 (TREM-1): a new player in antiviral immunity? Front Microbiol (2014) 0.84
The TREM2-DAP12 signaling pathway in Nasu-Hakola disease: a molecular genetics perspective. Res Rep Biochem (2015) 0.83
Downregulation of membrane type-matrix metalloproteinases in the inflamed or injured central nervous system. J Neuroinflammation (2007) 0.83
Central nervous system myeloid cells as drug targets: current status and translational challenges. Nat Rev Drug Discov (2015) 0.83
Triggering Receptor Expressed on Myeloid Cells-2 Correlates to Hypothermic Neuroprotection in Ischemic Stroke. Ther Hypothermia Temp Manag (2013) 0.82
The Triggering Receptor Expressed on Myeloid Cells 2: A Molecular Link of Neuroinflammation and Neurodegenerative Diseases. J Biol Chem (2015) 0.82
Development of a culture system to induce microglia-like cells from haematopoietic cells. Neuropathol Appl Neurobiol (2014) 0.82
Modeling CNS microglia: the quest to identify predictive models. Drug Discov Today Dis Models (2008) 0.81
Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease. J Neurosci (2017) 0.80
Differential modulation of TREM2 protein during postnatal brain development in mice. PLoS One (2013) 0.79
Complex molecular and functional outcomes of single versus sequential cytokine stimulation of rat microglia. J Neuroinflammation (2016) 0.77
A novel soluble immune-type receptor (SITR) in teleost fish: carp SITR is involved in the nitric oxide-mediated response to a protozoan parasite. PLoS One (2011) 0.77
Delayed glial clearance of degenerating axons in aged Drosophila is due to reduced PI3K/Draper activity. Nat Commun (2016) 0.76
Regulation of microglial survival and proliferation in health and diseases. Semin Immunol (2016) 0.76
Differential detection of impact site versus rotational site injury by magnetic resonance imaging and microglial morphology in an unrestrained mild closed head injury model. J Neurochem (2016) 0.76
The Receptor CMRF35-Like Molecule-1 (CLM-1) Enhances the Production of LPS-Induced Pro-Inflammatory Mediators during Microglial Activation. PLoS One (2015) 0.76
Double-stranded RNA analog and type I interferon regulate expression of Trem paired receptors in murine myeloid cells. BMC Immunol (2016) 0.75
The Indispensable Roles of Microglia and Astrocytes during Brain Development. Front Hum Neurosci (2016) 0.75
Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system. Curr Pharm Des (2014) 0.75
Regulation of microglial activation in stroke. Acta Pharmacol Sin (2017) 0.75
TREM2/DAP12 Complex Regulates Inflammatory Responses in Microglia via the JNK Signaling Pathway. Front Aging Neurosci (2017) 0.75
TREM2 in Neurodegenerative Diseases. Mol Neurodegener (2017) 0.75
The Pathophysiological Role of Microglia in Dynamic Surveillance, Phagocytosis and Structural Remodeling of the Developing CNS. Front Mol Neurosci (2017) 0.75
Modulation of Hematopoietic Lineage Specification Impacts TREM2 Expression in Microglia-Like Cells Derived From Human Stem Cells. ASN Neuro (2017) 0.75
Microglia: a sensor for pathological events in the CNS. Trends Neurosci (1996) 12.00
Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med (1999) 6.09
Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science (1988) 5.56
Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol (2000) 5.37
Immune function of microglia. Glia (2001) 4.59
Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science (2000) 4.41
Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc Natl Acad Sci U S A (1991) 4.07
Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am J Hum Genet (2002) 4.06
Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat Genet (2000) 3.39
A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J Exp Med (2001) 3.18
Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J Exp Med (2001) 2.90
Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med (1999) 2.84
DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity (2000) 2.75
Flow cytometric analysis of inflammatory cells in ischemic rat brain. Stroke (2002) 2.50
The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol (1999) 2.46
Mature microglia resemble immature antigen-presenting cells. Glia (1998) 2.28
CNS manifestations of Nasu-Hakola disease: a frontal dementia with bone cysts. Neurology (2001) 2.27
Innate immune recognition and control of adaptive immune responses. Semin Immunol (1998) 1.92
Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration. J Neurosci (1998) 1.87
Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines. J Leukoc Biol (1999) 1.84
Cloning and characterization of a novel mouse myeloid DAP12-associated receptor family. Eur J Immunol (2001) 1.78
Exacerbation of facial motoneuron loss after facial nerve transection in severe combined immunodeficient (scid) mice. J Neurosci (1999) 1.70
Brain-immune connection: immuno-regulatory properties of CNS-resident cells. Glia (2000) 1.70
Microglial response to brain injury: a brief synopsis. Toxicol Pathol (2000) 1.57
Leukocyte migration: scent of the T zone. Curr Biol (2000) 1.53
Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis. J Immunol (2001) 1.53
TOGA: an automated parsing technology for analyzing expression of nearly all genes. Proc Natl Acad Sci U S A (2000) 1.46
Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases. J Neuroimmunol (2002) 1.45
Microglia induce CD4 T lymphocyte final effector function and death. J Exp Med (1996) 1.44
Innate and adaptive immune responses can be beneficial for CNS repair. Trends Neurosci (1999) 1.44
A ligand for the chemokine receptor CCR7 can influence the homeostatic proliferation of CD4 T cells and progression of autoimmunity. J Immunol (2001) 1.43
Evidence for an early inflammatory response in the central nervous system of mice with scrapie. Neuroscience (1996) 1.38
Absence of donor-type major histocompatibility complex class I antigen-bearing microglia in the rat central nervous system of radiation bone marrow chimeras. J Neuroimmunol (1987) 1.37
The glucocorticoid attenuated response genes GARG-16, GARG-39, and GARG-49/IRG2 encode inducible proteins containing multiple tetratricopeptide repeat domains. Arch Biochem Biophys (1996) 1.35
Critical role of tumor necrosis factor-alpha and NF-kappa B in interferon-gamma -induced CD40 expression in microglia/macrophages. J Biol Chem (2002) 1.21
Disproportionate recruitment of CD8+ T cells into the central nervous system by professional antigen-presenting cells. Am J Pathol (1999) 1.17
Microglia stimulate naive T-cell differentiation without stimulating T-cell proliferation. J Neurosci Res (1999) 1.16
Integrating innate and adaptive immunity in the whole animal. Immunol Rev (1999) 1.08
Developmental expression of parvalbumin mRNA in the cerebral cortex and hippocampus of the rat. Brain Res Mol Brain Res (1995) 1.04
Differential expression of inflammatory mediators in rat microglia cultured from different brain regions. Brain Res Mol Brain Res (1999) 1.01
Differential regulation of metalloelastase activity in murine peritoneal macrophages by granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor. J Immunol (1996) 0.99
Molecular cloning and characterization of a murine LPS-inducible cDNA. J Immunol (1994) 0.98
Human focal cerebral infarctions induce differential lesional interleukin-16 (IL-16) expression confined to infiltrating granulocytes, CD8+ T-lymphocytes and activated microglia/macrophages. J Neuroimmunol (2001) 0.95
Ligation of microglial CD40 results in p44/42 mitogen-activated protein kinase-dependent TNF-alpha production that is opposed by TGF-beta 1 and IL-10. J Immunol (1999) 0.95
Site-specific immune regulation in the brain: differential modulation of major histocompatibility complex (MHC) proteins in brainstem vs. hippocampus. J Comp Neurol (1999) 0.94
Local immune regulation in the central nervous system by substance P vs. glutamate. J Neuroimmunol (2001) 0.94
Clozapine increases apolipoprotein D expression in rodent brain: towards a mechanism for neuroleptic pharmacotherapy. J Neurochem (2001) 0.92
Enriched immune-environment of blood-brain barrier deficient areas of normal adult rats. J Neuroimmunol (1997) 0.89
International network of cancer genome projects. Nature (2010) 20.35
Defining spoken language benchmarks and selecting measures of expressive language development for young children with autism spectrum disorders. J Speech Lang Hear Res (2009) 1.83
Peripheral reduction of β-amyloid is sufficient to reduce brain β-amyloid: implications for Alzheimer's disease. J Neurosci Res (2011) 1.80
CD4-positive T cell-mediated neuroprotection requires dual compartment antigen presentation. J Neurosci (2004) 1.71
Pincher, a pinocytic chaperone for nerve growth factor/TrkA signaling endosomes. J Cell Biol (2002) 1.69
Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease. ASN Neuro (2010) 1.58
Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease. J Neurochem (2006) 1.46
Molecular profiles of schizophrenia in the CNS at different stages of illness. Brain Res (2008) 1.46
8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents. Eur J Pharmacol (2004) 1.40
Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes. J Virol (2003) 1.39
5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern. Biol Psychiatry (2005) 1.34
Differential gene expression in LPS/IFNgamma activated microglia and macrophages: in vitro versus in vivo. J Neurochem (2009) 1.34
Targeted disruption of RC3 reveals a calmodulin-based mechanism for regulating metaplasticity in the hippocampus. J Neurosci (2002) 1.33
Joint variant and de novo mutation identification on pedigrees from high-throughput sequencing data. J Comput Biol (2014) 1.32
Functional, molecular and pharmacological advances in 5-HT7 receptor research. Trends Pharmacol Sci (2004) 1.30
Microglia and the control of autoreactive T cell responses. Neurochem Int (2006) 1.28
Developmental regulation of TREM2 and DAP12 expression in the murine CNS: implications for Nasu-Hakola disease. Neurochem Res (2008) 1.27
Fenofibrate represses interleukin-17 and interferon-gamma expression and improves colitis in interleukin-10-deficient mice. Gastroenterology (2007) 1.18
Mice lacking 5-HT receptors show specific impairments in contextual learning. Eur J Neurosci (2004) 1.15
The hypocretins and sleep. FEBS J (2005) 1.15
Cell culture modeling of specialized tissue: identification of genes expressed specifically by follicle-associated epithelium of Peyer's patch by expression profiling of Caco-2/Raji co-cultures. Int Immunol (2004) 1.11
Identification of complement 5a-like receptor (C5L2) from astrocytes: characterization of anti-inflammatory properties. J Neurochem (2005) 1.10
P2X4 receptors in activated C8-B4 cells of cerebellar microglial origin. J Gen Physiol (2010) 1.07
Bone marrow transplantation confers modest benefits in mouse models of Huntington's disease. J Neurosci (2012) 1.03
Leukocyte infiltration, but not neurodegeneration, in the CNS of transgenic mice with astrocyte production of the CXC chemokine ligand 10. J Immunol (2002) 1.03
CCR7-dependent immunity during acute Toxoplasma gondii infection. Infect Immun (2010) 1.00
CNS-derived CCL21 is both sufficient to drive homeostatic CD4+ T cell proliferation and necessary for efficient CD4+ T cell migration into the CNS parenchyma following Toxoplasma gondii infection. Brain Behav Immun (2010) 0.99
Normal human aging and early-stage schizophrenia share common molecular profiles. Aging Cell (2009) 0.99
Glycolipid and ganglioside metabolism imbalances in Huntington's disease. Neurobiol Dis (2007) 0.93
NeuroAIDS, drug abuse, and inflammation: building collaborative research activities. J Neuroimmune Pharmacol (2006) 0.91
Lymphotoxin beta receptor (Lt betaR): dual roles in demyelination and remyelination and successful therapeutic intervention using Lt betaR-Ig protein. J Neurosci (2007) 0.90
Hypocretins/orexins as integrators of physiological information: lessons from mutant animals. Neuropeptides (2002) 0.90
Apolipoprotein D levels are elevated in prefrontal cortex of subjects with Alzheimer's disease: no relation to apolipoprotein E expression or genotype. Biol Psychiatry (2003) 0.90
Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition. Biol Psychiatry (2007) 0.88
Are international differences in the outcomes of acute coronary syndromes apparent or real? A multilevel analysis. J Epidemiol Community Health (2005) 0.87
Upregulation of the stress-associated gene p8 in mouse models of demyelination and in multiple sclerosis tissues. Glia (2006) 0.86
Regulation of alpha-synuclein expression in limbic and motor brain regions of morphine-treated mice. J Neurosci (2005) 0.85
LPS-induced CCL2 expression and macrophage influx into the murine central nervous system is polyamine-dependent. Brain Behav Immun (2011) 0.85
Induction of Golli-MBP expression in CNS macrophages during acute LPS-induced CNS inflammation and experimental autoimmune encephalomyelitis (EAE). ScientificWorldJournal (2007) 0.85
Aberrant recombination involving the granzyme locus occurs in Atm-/- T-cell lymphomas. Hum Mol Genet (2005) 0.85
Hypocretin is an early member of the incretin gene family. Neurosci Lett (2002) 0.84
The 5-HT7 receptor influences stereotypic behavior in a model of obsessive-compulsive disorder. Neurosci Lett (2007) 0.83
Apolipoprotein D modulates arachidonic acid signaling in cultured cells: implications for psychiatric disorders. Prostaglandins Leukot Essent Fatty Acids (2003) 0.83
Computational analysis reveals increased blood deposition following repeated mild traumatic brain injury. Neuroimage Clin (2012) 0.81
A new UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase mRNA exhibits predominant expression in the hypothalamus, thalamus and amygdala of mouse forebrain. Brain Res Gene Expr Patterns (2002) 0.80
Novel isoform of insulin receptor substrate p53/p58 is generated by alternative splicing in the CRIB/SH3-binding region. J Biol Chem (2002) 0.80
Induction and effector phase of allergic lung inflammation is independent of CCL21/CCL19 and LT-beta. Int J Med Sci (2009) 0.80
Glial cells as primary therapeutic targets for epilepsy. Neurochem Int (2013) 0.80
Standardized quantitative in situ hybridization using radioactive oligonucleotide probes for detecting relative levels of mRNA transcripts verified by real-time PCR. Brain Res (2004) 0.78
When the tail can't wag the dog: the implications of CNS-intrinsic initiation of neuroinflammation. ASN Neuro (2009) 0.78
New prospects and strategies for drug target discovery in neurodegenerative disorders. NeuroRx (2005) 0.75
A novel mRNA expressed along brain ventricles. Brain Res Gene Expr Patterns (2002) 0.75
Not asleep, not quite awake. Nat Med (2004) 0.75
Open system gene expression profiling and identification of novel genes for targeted vaccine delivery. Expert Rev Vaccines (2002) 0.75